Global Nuclear Medicine/Radiopharmaceutic Market Research Report 2018

Published Date : 2018-11-09

Published By : Qy Research Groups

Category : Pharma & Healthcare

No. of Pages : 146



This report studies the global Nuclear Medicine/Radiopharmaceutic market status and forecast, categorizes the global Nuclear Medicine/Radiopharmaceutic market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

The major manufacturers covered in this report
Company
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
总部所在国
Italy
Germany
UK
Canada
USA
USA
Belgium
USA
China

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Diagnostic Radioisotopes
Therapeutic Radioisotopes
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Oncology
Cardiology
Others

The study objectives of this report are:
To analyze and study the global Nuclear Medicine/Radiopharmaceutic capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Nuclear Medicine/Radiopharmaceutic manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Nuclear Medicine/Radiopharmaceutic are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Nuclear Medicine/Radiopharmaceutic Manufacturers
Nuclear Medicine/Radiopharmaceutic Distributors/Traders/Wholesalers
Nuclear Medicine/Radiopharmaceutic Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Nuclear Medicine/Radiopharmaceutic market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global Nuclear Medicine/Radiopharmaceutic Market Research Report 2018
1 Nuclear Medicine/Radiopharmaceutic Market Overview
1.1 Product Overview and Scope of Nuclear Medicine/Radiopharmaceutic
1.2 Nuclear Medicine/Radiopharmaceutic Segment by Type (Product Category)
1.2.1 Global Nuclear Medicine/Radiopharmaceutic Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Nuclear Medicine/Radiopharmaceutic Production Market Share by Type (Product Category) in 2017
1.2.3 Diagnostic Radioisotopes
1.2.3 Therapeutic Radioisotopes
1.3 Global Nuclear Medicine/Radiopharmaceutic Segment by Application
1.3.1 Nuclear Medicine/Radiopharmaceutic Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Others
1.4 Global Nuclear Medicine/Radiopharmaceutic Market by Region (2013-2025)
1.4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Nuclear Medicine/Radiopharmaceutic (2013-2025)
1.5.1 Global Nuclear Medicine/Radiopharmaceutic Revenue Status and Outlook (2013-2025)
1.5.2 Global Nuclear Medicine/Radiopharmaceutic Capacity, Production Status and Outlook (2013-2025)

2 Global Nuclear Medicine/Radiopharmaceutic Market Competition by Manufacturers
2.1 Global Nuclear Medicine/Radiopharmaceutic Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Nuclear Medicine/Radiopharmaceutic Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Nuclear Medicine/Radiopharmaceutic Production and Share by Manufacturers (2013-2018)
2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Share by Manufacturers (2013-2018)
2.3 Global Nuclear Medicine/Radiopharmaceutic Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Nuclear Medicine/Radiopharmaceutic Manufacturing Base Distribution, Sales Area and Product Type
2.5 Nuclear Medicine/Radiopharmaceutic Market Competitive Situation and Trends
2.5.1 Nuclear Medicine/Radiopharmaceutic Market Concentration Rate
2.5.2 Nuclear Medicine/Radiopharmaceutic Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Nuclear Medicine/Radiopharmaceutic Capacity and Market Share by Region (2013-2018)
3.2 Global Nuclear Medicine/Radiopharmaceutic Production and Market Share by Region (2013-2018)
3.3 Global Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Nuclear Medicine/Radiopharmaceutic Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Nuclear Medicine/Radiopharmaceutic Consumption by Region (2013-2018)
4.2 North America Nuclear Medicine/Radiopharmaceutic Production, Consumption, Export, Import (2013-2018)
4.3 Europe Nuclear Medicine/Radiopharmaceutic Production, Consumption, Export, Import (2013-2018)
4.4 China Nuclear Medicine/Radiopharmaceutic Production, Consumption, Export, Import (2013-2018)
4.5 Japan Nuclear Medicine/Radiopharmaceutic Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Nuclear Medicine/Radiopharmaceutic Production, Consumption, Export, Import (2013-2018)
4.7 India Nuclear Medicine/Radiopharmaceutic Production, Consumption, Export, Import (2013-2018)

5 Global Nuclear Medicine/Radiopharmaceutic Production, Revenue (Value), Price Trend by Type
5.1 Global Nuclear Medicine/Radiopharmaceutic Production and Market Share by Type (2013-2018)
5.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Type (2013-2018)
5.3 Global Nuclear Medicine/Radiopharmaceutic Price by Type (2013-2018)
5.4 Global Nuclear Medicine/Radiopharmaceutic Production Growth by Type (2013-2018)

6 Global Nuclear Medicine/Radiopharmaceutic Market Analysis by Application
6.1 Global Nuclear Medicine/Radiopharmaceutic Consumption and Market Share by Application (2013-2018)
6.2 Global Nuclear Medicine/Radiopharmaceutic Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Nuclear Medicine/Radiopharmaceutic Manufacturers Profiles/Analysis
7.1 Company
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Company Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Bracco Imaging
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Bayer
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Bayer Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Mallinckrodt
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Nordion
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Nordion Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Triad Isotopes
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Triad Isotopes Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Lantheus
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Lantheus Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 IBA Group
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 IBA Group Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 GE Healthcare
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.8 China Isotope & Radiation
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 Jubilant Pharma
7.12 Eli Lilly
7.13 Advanced Accelerator Applications
7.14 SIEMENS
7.15 Dongcheng
7.16 Navidea
7.31 总部所在国
7.32 Italy
7.33 Germany
7.34 UK
7.35 Canada
7.36 USA
7.37 USA
7.38 Belgium
7.39 USA
7.40 China

8 Nuclear Medicine/Radiopharmaceutic Manufacturing Cost Analysis
8.1 Nuclear Medicine/Radiopharmaceutic Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Nuclear Medicine/Radiopharmaceutic Major Manufacturers in 2017
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Nuclear Medicine/Radiopharmaceutic Market Forecast (2018-2025)
12.1 Global Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Nuclear Medicine/Radiopharmaceutic Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Nuclear Medicine/Radiopharmaceutic Price and Trend Forecast (2018-2025)
12.2 Global Nuclear Medicine/Radiopharmaceutic Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Nuclear Medicine/Radiopharmaceutic Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Nuclear Medicine/Radiopharmaceutic Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Nuclear Medicine/Radiopharmaceutic Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Nuclear Medicine/Radiopharmaceutic Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Nuclear Medicine/Radiopharmaceutic Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Nuclear Medicine/Radiopharmaceutic Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Nuclear Medicine/Radiopharmaceutic Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Nuclear Medicine/Radiopharmaceutic Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer


List of Tables and Figures

Figure Picture of Nuclear Medicine/Radiopharmaceutic
Figure Global Nuclear Medicine/Radiopharmaceutic Production (M Dose) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Diagnostic Radioisotopes
Table Major Manufacturers of Diagnostic Radioisotopes
Figure Product Picture of Therapeutic Radioisotopes
Table Major Manufacturers of Therapeutic Radioisotopes
Figure Global Nuclear Medicine/Radiopharmaceutic Consumption (M Dose) by Applications (2013-2025)
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Cardiology Examples
Table Key Downstream Customer in Cardiology
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Nuclear Medicine/Radiopharmaceutic Market Size (Million USD), Comparison (M Dose) and CAGR (%) by Regions (2013-2025)
Figure North America Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose) Status and Outlook (2013-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Major Players Product Capacity (M Dose) (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Capacity (M Dose) of Key Manufacturers (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceutic Capacity (M Dose) of Key Manufacturers in 2017
Figure Global Nuclear Medicine/Radiopharmaceutic Capacity (M Dose) of Key Manufacturers in 2018
Figure Global Nuclear Medicine/Radiopharmaceutic Major Players Product Production (M Dose) (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Production (M Dose) of Key Manufacturers (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Production Share by Manufacturers (2013-2018)
Figure 2017 Nuclear Medicine/Radiopharmaceutic Production Share by Manufacturers
Figure 2017 Nuclear Medicine/Radiopharmaceutic Production Share by Manufacturers
Figure Global Nuclear Medicine/Radiopharmaceutic Major Players Product Revenue (Million USD) (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers
Table 2018 Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers
Table Global Market Nuclear Medicine/Radiopharmaceutic Average Price (USD/Dose) of Key Manufacturers (2013-2018)
Figure Global Market Nuclear Medicine/Radiopharmaceutic Average Price (USD/Dose) of Key Manufacturers in 2017
Table Manufacturers Nuclear Medicine/Radiopharmaceutic Manufacturing Base Distribution and Sales Area
Table Manufacturers Nuclear Medicine/Radiopharmaceutic Product Category
Figure Nuclear Medicine/Radiopharmaceutic Market Share of Top 3 Manufacturers
Figure Nuclear Medicine/Radiopharmaceutic Market Share of Top 5 Manufacturers
Table Global Nuclear Medicine/Radiopharmaceutic Capacity (M Dose) by Region (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceutic Capacity Market Share by Region (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceutic Capacity Market Share by Region (2013-2018)
Figure 2017 Global Nuclear Medicine/Radiopharmaceutic Capacity Market Share by Region
Table Global Nuclear Medicine/Radiopharmaceutic Production by Region (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceutic Production (M Dose) by Region (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceutic Production Market Share by Region (2013-2018)
Figure 2017 Global Nuclear Medicine/Radiopharmaceutic Production Market Share by Region
Table Global Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) by Region (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2013-2018)
Table 2017 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region
Figure Global Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose) and Growth Rate (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table North America Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table China Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Japan Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Southeast Asia Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table India Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Consumption (M Dose) Market by Region (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Consumption Market Share by Region (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceutic Consumption Market Share by Region (2013-2018)
Figure 2017 Global Nuclear Medicine/Radiopharmaceutic Consumption (M Dose) Market Share by Region
Table North America Nuclear Medicine/Radiopharmaceutic Production, Consumption, Import & Export (M Dose) (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceutic Production, Consumption, Import & Export (M Dose) (2013-2018)
Table China Nuclear Medicine/Radiopharmaceutic Production, Consumption, Import & Export (M Dose) (2013-2018)
Table Japan Nuclear Medicine/Radiopharmaceutic Production, Consumption, Import & Export (M Dose) (2013-2018)
Table Southeast Asia Nuclear Medicine/Radiopharmaceutic Production, Consumption, Import & Export (M Dose) (2013-2018)
Table India Nuclear Medicine/Radiopharmaceutic Production, Consumption, Import & Export (M Dose) (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Production (M Dose) by Type (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Production Share by Type (2013-2018)
Figure Production Market Share of Nuclear Medicine/Radiopharmaceutic by Type (2013-2018)
Figure 2017 Production Market Share of Nuclear Medicine/Radiopharmaceutic by Type
Table Global Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) by Type (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Nuclear Medicine/Radiopharmaceutic by Type (2013-2018)
Figure 2017 Revenue Market Share of Nuclear Medicine/Radiopharmaceutic by Type
Table Global Nuclear Medicine/Radiopharmaceutic Price (USD/Dose) by Type (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceutic Production Growth by Type (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Consumption (M Dose) by Application (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Consumption Market Share by Application (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceutic Consumption Market Share by Applications (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceutic Consumption Market Share by Application in 2017
Table Global Nuclear Medicine/Radiopharmaceutic Consumption Growth Rate by Application (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceutic Consumption Growth Rate by Application (2013-2018)
Table Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Company Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Company Nuclear Medicine/Radiopharmaceutic Production Growth Rate (2013-2018)
Figure Company Nuclear Medicine/Radiopharmaceutic Production Market Share (2013-2018)
Figure Company Nuclear Medicine/Radiopharmaceutic Revenue Market Share (2013-2018)
Table Bracco Imaging Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bracco Imaging Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bracco Imaging Nuclear Medicine/Radiopharmaceutic Production Growth Rate (2013-2018)
Figure Bracco Imaging Nuclear Medicine/Radiopharmaceutic Production Market Share (2013-2018)
Figure Bracco Imaging Nuclear Medicine/Radiopharmaceutic Revenue Market Share (2013-2018)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bayer Nuclear Medicine/Radiopharmaceutic Production Growth Rate (2013-2018)
Figure Bayer Nuclear Medicine/Radiopharmaceutic Production Market Share (2013-2018)
Figure Bayer Nuclear Medicine/Radiopharmaceutic Revenue Market Share (2013-2018)
Table Mallinckrodt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceutic Production Growth Rate (2013-2018)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceutic Production Market Share (2013-2018)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceutic Revenue Market Share (2013-2018)
Table Nordion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nordion Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Nordion Nuclear Medicine/Radiopharmaceutic Production Growth Rate (2013-2018)
Figure Nordion Nuclear Medicine/Radiopharmaceutic Production Market Share (2013-2018)
Figure Nordion Nuclear Medicine/Radiopharmaceutic Revenue Market Share (2013-2018)
Table Triad Isotopes Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Triad Isotopes Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Triad Isotopes Nuclear Medicine/Radiopharmaceutic Production Growth Rate (2013-2018)
Figure Triad Isotopes Nuclear Medicine/Radiopharmaceutic Production Market Share (2013-2018)
Figure Triad Isotopes Nuclear Medicine/Radiopharmaceutic Revenue Market Share (2013-2018)
Table Lantheus Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lantheus Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Lantheus Nuclear Medicine/Radiopharmaceutic Production Growth Rate (2013-2018)
Figure Lantheus Nuclear Medicine/Radiopharmaceutic Production Market Share (2013-2018)
Figure Lantheus Nuclear Medicine/Radiopharmaceutic Revenue Market Share (2013-2018)
Table IBA Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table IBA Group Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure IBA Group Nuclear Medicine/Radiopharmaceutic Production Growth Rate (2013-2018)
Figure IBA Group Nuclear Medicine/Radiopharmaceutic Production Market Share (2013-2018)
Figure IBA Group Nuclear Medicine/Radiopharmaceutic Revenue Market Share (2013-2018)
Table GE Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceutic Production Growth Rate (2013-2018)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceutic Production Market Share (2013-2018)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceutic Revenue Market Share (2013-2018)
Table China Isotope & Radiation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Production Growth Rate (2013-2018)
Figure China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Production Market Share (2013-2018)
Figure China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceutic
Figure Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic
Figure Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine/Radiopharmaceutic Major Manufacturers in 2017
Table Major Buyers of Nuclear Medicine/Radiopharmaceutic
Table Distributors/Traders List
Figure Global Nuclear Medicine/Radiopharmaceutic Capacity, Production (M Dose) and Growth Rate Forecast (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Price (Million USD) and Trend Forecast (2018-2025)
Table Global Nuclear Medicine/Radiopharmaceutic Production (M Dose) Forecast by Region (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Production Market Share Forecast by Region (2018-2025)
Table Global Nuclear Medicine/Radiopharmaceutic Consumption (M Dose) Forecast by Region (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Consumption Market Share Forecast by Region (2018-2025)
Figure North America Nuclear Medicine/Radiopharmaceutic Production (M Dose) and Growth Rate Forecast (2018-2025)
Figure North America Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Nuclear Medicine/Radiopharmaceutic Production, Consumption, Export and Import (M Dose) Forecast (2018-2025)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Production (M Dose) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Production, Consumption, Export and Import (M Dose) Forecast (2018-2025)
Figure Europe Nuclear Medicine/Radiopharmaceutic Production (M Dose) and Growth Rate Forecast (2018-2025)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Nuclear Medicine/Radiopharmaceutic Production, Consumption, Export and Import (M Dose) Forecast (2018-2025)
Figure Central & South America Nuclear Medicine/Radiopharmaceutic Production (M Dose) and Growth Rate Forecast (2018-2025)
Figure Central & South America Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Central & South America Nuclear Medicine/Radiopharmaceutic Production, Consumption, Export and Import (M Dose) Forecast (2018-2025)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Production (M Dose) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Nuclear Medicine/Radiopharmaceutic Production, Consumption, Export and Import (M Dose) Forecast (2018-2025)
Figure India Nuclear Medicine/Radiopharmaceutic Production (M Dose) and Growth Rate Forecast (2018-2025)
Figure India Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Nuclear Medicine/Radiopharmaceutic Production, Consumption, Export and Import (M Dose) Forecast (2018-2025)
Table Global Nuclear Medicine/Radiopharmaceutic Production (M Dose) Forecast by Type (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Production (M Dose) Forecast by Type (2018-2025)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Type (2018-2025)
Table Global Nuclear Medicine/Radiopharmaceutic Price Forecast by Type (2018-2025)
Table Global Nuclear Medicine/Radiopharmaceutic Consumption (M Dose) Forecast by Application (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Consumption (M Dose) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source

Nuclear Medicine/Radiopharmaceutic  Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-236-2744

sales@qyresearchgroups.com